谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Could S-1-based Non-Platinum Doublet Chemotherapy Be a New Option As a Second-Line Treatment for Advanced Non-Small Cell Lung Cancer Patients? A Multicenter Retrospective Study.

Xiangling Wang, Ting Wang,Yunxia Chu,Jie Liu,Cuihua Yi,Xuejun Yu, Yonggang Wang,Tianying Zheng,Fangli Cao,Linli Qu, Bo Yu,Huayong Liu,Fei Ding, Shuang Wang,Xiangbo Wang,Jing Hao,Xiuwen Wang

Frontiers in oncology（2023）

引用 0|浏览2
暂无评分
关键词
non-small cell lung cancer,second-line treatment,S-1,gemcitabine,docetaxel
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要